This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as Hybrid Event from 15-17 November 2021
Live In-Person Conference Delivered 15-17 NovemberSheraton Airport Brussels, Belgium

Frédéric Legros
Chief Operating Officer at Dynacure


Dr. Frédéric Legros is an established biotech leader with more than 20 years of experience in the biotechnology industry who is serving as Chief Operating Officer for Dynacure since its inception. He is overseeing corporate and business development, IP, legal and CMC activities and is a key member of the executive management team. Before joining Dynacure, Frédéric was Vice President and Corporate Head of Business Development of Valneva SE, a listed company on the French stock exchange, where he strongly participated to the development of its pipeline of vaccines. Frédéric served on the board of directors of the French biotechnology company Blink Biomedical, which is dedicated to the development of novel antibodies in the field of immune checkpoint targets in cancer. Frédéric was also Director of the Pasteur Institute’s Tech Transfer office, where he was in charge of the licensing portfolio and strategic partnerships.He studied biotechnology at University of Paris 7, obtained his PhD in molecular biology (2002), and published several publications in peer-reviewed journals while at the Institute of Myology (Paris). He also holds a business degree from NEOMA Business School, France (2003).

Agenda Sessions

  • An Antisense Oligonucleotide-mediated Therapeutic Approach for the Treatment of Centronuclear Myopathies